CONMED Corporation Reports Q1 2026 Financial Results
CONMED Corporation reported financial results for the first quarter of 2026, with sales totaling $317.0 million, reflecting a 1.3% decrease year-over-year. The decline was largely attributed to the exit from specific GI products, resulting in a $15.5 million drop in sales. Domestic revenues saw a 5.8% decrease as well, influenced by a reduction of $15.2 million in domestic sales.
LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Sales of $317.0 million decreased 1.3% year-over-year as reported and 2.9% in constant currency. Net sales growth was impacted by a $15.5 million decrease in sales from the exit of certain GI products. Domestic revenue decreased 5.8% year-over-year. Domestic sales growth was impacted by a $15.2 million decrease in sales from th